ZNA Chooses Mindpeak PD-L1 BENELUX first: ZNA and GZA Hospitals use smart software for cancer diagnosis Artificial intelligence provides faster and more accurate assessment of millions of tumor cells As the first in Belgium, the...

SAN FRANCISCO, Dec. 2, 2022 /PRNewswire/ -- JelloX Biotech is celebrating a robust year of research and product development milestones while showcasing the potential for 3D imaging and AI to be the future of cancer pathology. Presently,...

Indica Labs has announced their latest webinar. Tumor-specific Tumor-resident Cytotoxic T Cells Predict Recurrence In Stage III Melanoma Patients Treated With Adjuvant Immunotherapy 20 January 2022 2:00pm - 3:00pm PST | 5:00pm -...

NEW YORK – Artificial intelligence company Nucleai and Jefferson Health on Tuesday announced a collaboration to discover histological biomarkers that predict response to immunotherapy. Tel Aviv-based Nucleai will use its ATOM platform to...

Join us for a complimentary joint Visiopharm & Ultivue webinar! Advanced Phenotyping of the Tumor Immune Microenvironment MAY 26, 2021 | 9:00AM (PDT) | 12:00PM (EDT) | 6:00PM (CET) Register Now Immunotherapy has transformed the...

CIRECA marks a new look at Tumors, Immunity and the Micro-Environment (TIME) in the Classification and Discovery of Cancerous Cells and Immune Response using Spectral Histopathology (SHP) CAMBRIDGE, MASS. (PRWEB) JUNE 10, 2018 -- CIRECA, a...